Search
AtriCure Inc
ATRCAdd to Watchlist
58.540USD
-2.740-4.47%
Close 11-06 16:00（ET）
2.98BMarket Cap
LossP/E TTM
AtriCure Inc (ATRC) Stock Price Target & Forecast
Analyst Rating
Based on 10 analysts giving stock ratings to AtriCure Inc in the past month.
Buy
2 Strong Buy
5 Buy
3 Hold
0 Sell
0 Strong Sell
Target Price
61.714USD+0.76%
ATRC Analyst Recommendation Trends
In the current month, ATRC has received 5 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. ATRC average Analyst price target in the last month is 61.714.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2
2
2
2
2
2
2
2
5
6
6
6
6
6
5
5
3
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
10
10
10
10
9
9
ATRC Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Stryker Corp
SYK
10
14
6
0
0
30
Dexcom Inc
DXCM
13
12
4
0
0
29
Medtronic PLC
MDT
8
11
10
0
0
29
Medline Ord Shs Class A
MDLN
10
12
6
0
0
28
Guardant Health Inc
GH
12
14
2
0
0
28
Abbott Laboratories
ABT
11
13
4
0
0
28
Zimmer Biomet Holdings Inc
ZBH
2
5
20
0
0
27
Insulet Corp
PODD
7
7
12
0
0
26
Tandem Diabetes Care Inc
TNDM
5
8
10
0
0
23
Repligen Corp
RGEN
5
12
4
0
0
21
Financial Forecasting
Based on analysts' estimates, ATRC EPS is projected to reach 0.008 in FY2026Q4, following reported EPS of 0.083 in FY2026Q3. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
FY2027Q1
Forecast
-0.06
0.00
-0.05
0.01
0.03
Actual
0.00
0.18
0.08
--
--
Surprise
+103.79%
+4044.37%
+262.63%
--
--
FAQs
What is AtriCure Inc's expected revenue for the next quarter?
AtriCure Inc's expected revenue is 159.53M.
What is AtriCure Inc's price target?
Analysts forecast that AtriCure Inc's price target is USD 66.75, with the highest forecast at USD 70.00 and the lowest forecast at USD 57.00.
How have AtriCure IncATRC's recent earnings per share performed?
The market expectation was USD 0.08, while AtriCure IncATRC's earnings per share (EPS) for the previous quarter was USD 0.18. EPS for the next quarter is expected at USD 0.01.
What is the analyst rating for AtriCure Inc?
Based on the ratings of AtriCure Inc's stock from 10 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.